Kintor Pharmaceutical Limited at its AGM held on June 20, 2024, announced that with effect from the close of the AGM, Dr. Qun LU (?Dr. LU?), an executive Director and Mr. Chengwei LIU (?Mr. LIU?), a non-executive Director have retired at the AGM and did not offer themselves for re-election as executive Director and non- executive Director of the Company due to personal commitments. Following the retirement of Mr. LIU as a non-executive Director, Mr. LIU has also ceased to be a member of the audit committee of the Company. The Board further announced that Prof. Liang Tong, an independent non-executive Director has been appointed as a member of the Audit Committee with effect from the close of the AGM.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 HKD | -4.59% | -5.45% | -36.20% |
EPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-36.20% | 58.52M | |
+15.20% | 121B | |
+19.67% | 113B | |
+18.95% | 26.02B | |
-23.86% | 19.39B | |
-19.03% | 15.91B | |
-20.90% | 15.09B | |
-46.14% | 15.06B | |
+63.85% | 14.93B | |
+4.49% | 13.85B |
- Stock Market
- Equities
- 9939 Stock
- News Kintor Pharmaceutical Limited
- Kintor Pharmaceutical Limited Announces Retirement of Directors and Change in Composition of the Audit Committee